位置:首页 > 蛋白库 > 4EBP3_HUMAN
4EBP3_HUMAN
ID   4EBP3_HUMAN             Reviewed;         100 AA.
AC   O60516;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   03-AUG-2022, entry version 151.
DE   RecName: Full=Eukaryotic translation initiation factor 4E-binding protein 3;
DE            Short=4E-BP3;
DE            Short=eIF4E-binding protein 3;
GN   Name=EIF4EBP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH EIF4E, MUTAGENESIS OF TYR-40
RP   AND LEU-45, TISSUE SPECIFICITY, AND PHOSPHORYLATION.
RX   PubMed=9593750; DOI=10.1074/jbc.273.22.14002;
RA   Poulin F., Gingras A.-C., Olsen H., Chevalier S., Sonenberg N.;
RT   "4E-BP3, a new member of the eukaryotic initiation factor 4E-binding
RT   protein family.";
RL   J. Biol. Chem. 273:14002-14007(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Repressor of translation initiation that regulates EIF4E
CC       activity by preventing its assembly into the eIF4F complex:
CC       hypophosphorylated form competes with EIF4G1/EIF4G3 and strongly binds
CC       to EIF4E, leading to repress translation. In contrast,
CC       hyperphosphorylated form dissociates from EIF4E, allowing interaction
CC       between EIF4G1/EIF4G3 and EIF4E, leading to initiation of translation.
CC       {ECO:0000250|UniProtKB:Q13541}.
CC   -!- SUBUNIT: EIF4EBP3 interacts with EIF4E. {ECO:0000269|PubMed:9593750}.
CC   -!- INTERACTION:
CC       O60516; P06730: EIF4E; NbExp=9; IntAct=EBI-746950, EBI-73440;
CC       O60516; P15927: RPA2; NbExp=3; IntAct=EBI-746950, EBI-621404;
CC       O60516; Q80ZJ3: Eif4e2; Xeno; NbExp=2; IntAct=EBI-746950, EBI-934970;
CC   -!- TISSUE SPECIFICITY: Expression is highest in skeletal muscle, heart,
CC       kidney, and pancreas, whereas there is very little expression in brain
CC       and thymus. {ECO:0000269|PubMed:9593750}.
CC   -!- PTM: Phosphorylated. {ECO:0000269|PubMed:9593750}.
CC   -!- SIMILARITY: Belongs to the eIF4E-binding protein family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF038869; AAC39761.1; -; mRNA.
DR   EMBL; BC010881; AAH10881.1; -; mRNA.
DR   EMBL; BC069293; AAH69293.1; -; mRNA.
DR   EMBL; BC073751; AAH73751.1; -; mRNA.
DR   CCDS; CCDS4226.1; -.
DR   RefSeq; NP_003723.1; NM_003732.2.
DR   AlphaFoldDB; O60516; -.
DR   SMR; O60516; -.
DR   BioGRID; 114190; 10.
DR   ELM; O60516; -.
DR   IntAct; O60516; 5.
DR   MINT; O60516; -.
DR   STRING; 9606.ENSP00000308472; -.
DR   iPTMnet; O60516; -.
DR   PhosphoSitePlus; O60516; -.
DR   BioMuta; EIF4EBP3; -.
DR   EPD; O60516; -.
DR   jPOST; O60516; -.
DR   MassIVE; O60516; -.
DR   PaxDb; O60516; -.
DR   PeptideAtlas; O60516; -.
DR   PRIDE; O60516; -.
DR   ProteomicsDB; 49454; -.
DR   Antibodypedia; 34915; 131 antibodies from 18 providers.
DR   DNASU; 8637; -.
DR   Ensembl; ENST00000310331.3; ENSP00000308472.2; ENSG00000243056.2.
DR   GeneID; 8637; -.
DR   KEGG; hsa:8637; -.
DR   MANE-Select; ENST00000310331.3; ENSP00000308472.2; NM_003732.3; NP_003723.1.
DR   UCSC; uc003lfy.1; human.
DR   CTD; 8637; -.
DR   DisGeNET; 8637; -.
DR   GeneCards; EIF4EBP3; -.
DR   HGNC; HGNC:3290; EIF4EBP3.
DR   HPA; ENSG00000243056; Low tissue specificity.
DR   MIM; 603483; gene.
DR   neXtProt; NX_O60516; -.
DR   OpenTargets; ENSG00000243056; -.
DR   PharmGKB; PA27718; -.
DR   VEuPathDB; HostDB:ENSG00000243056; -.
DR   eggNOG; ENOG502S03G; Eukaryota.
DR   GeneTree; ENSGT00940000163328; -.
DR   HOGENOM; CLU_111706_0_0_1; -.
DR   InParanoid; O60516; -.
DR   OMA; YSTTPHG; -.
DR   OrthoDB; 1597535at2759; -.
DR   PhylomeDB; O60516; -.
DR   TreeFam; TF101530; -.
DR   PathwayCommons; O60516; -.
DR   SignaLink; O60516; -.
DR   SIGNOR; O60516; -.
DR   BioGRID-ORCS; 8637; 6 hits in 1075 CRISPR screens.
DR   GeneWiki; EIF4EBP3; -.
DR   GenomeRNAi; 8637; -.
DR   Pharos; O60516; Tbio.
DR   PRO; PR:O60516; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; O60516; protein.
DR   Bgee; ENSG00000243056; Expressed in right uterine tube and 92 other tissues.
DR   Genevisible; O60516; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0016281; C:eukaryotic translation initiation factor 4F complex; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0008190; F:eukaryotic initiation factor 4E binding; IBA:GO_Central.
DR   GO; GO:0030371; F:translation repressor activity; NAS:UniProtKB.
DR   GO; GO:0045947; P:negative regulation of translational initiation; IBA:GO_Central.
DR   InterPro; IPR008606; EIF4EBP.
DR   Pfam; PF05456; eIF_4EBP; 1.
PE   1: Evidence at protein level;
KW   Phosphoprotein; Protein synthesis inhibitor; Reference proteome;
KW   Translation regulation.
FT   CHAIN           1..100
FT                   /note="Eukaryotic translation initiation factor 4E-binding
FT                   protein 3"
FT                   /id="PRO_0000190518"
FT   REGION          81..100
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           40..46
FT                   /note="YXXXXLphi motif"
FT                   /evidence="ECO:0000269|PubMed:9593750"
FT   MOTIF           96..100
FT                   /note="TOS motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q13541"
FT   COMPBIAS        85..100
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MUTAGEN         40
FT                   /note="Y->A: Loss of interaction with EIF4E."
FT                   /evidence="ECO:0000269|PubMed:9593750"
FT   MUTAGEN         45
FT                   /note="L->A: Loss of interaction with EIF4E."
FT                   /evidence="ECO:0000269|PubMed:9593750"
SQ   SEQUENCE   100 AA;  10873 MW;  FD29A7F3829E546E CRC64;
     MSTSTSCPIP GGRDQLPDCY STTPGGTLYA TTPGGTRIIY DRKFLLECKN SPIARTPPCC
     LPQIPGVTTP PTAPLSKLEE LKEQETEEEI PDDAQFEMDI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024